TRIBUNWOW.COM – The United States National Institutes of Health (NIH) is assessing the possible long-term impact Covid-19 to pregnant women.
Because, Covid-19 has been known to cause many symptoms and prolonged symptoms in survivors.
It can even have an impact on patients who during the acute period of infection only experience mild symptoms.
Also read: Including mild symptoms, study reveals Covid-19 survivors with brain fog have increased
Reported from the official page NIH, explained that the study would follow up 1,500 pregnant patients with Covid-19 and the baby she gave birth to for four years.
The study will also follow their offspring for potential long-term effects.
This effort is part of Covid Studi Initiative, which aims to understand why some individuals suffer Covid-19 not fully recovered or experiencing symptoms after recovery.
Or the phenomenon known as long Covid or post-Covid symptoms, this condition affects all ages, genders, and even occurs in previously healthy people.
Long-term effects include fatigue, shortness of breath, difficulty concentrating, sleep disturbances, fever, anxiety and depression.
The current study will enroll some participants from previous studies by the Network of Maternal-Fetal Medicine Units (MFMU), a 36-site research collaboration supported by the NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Participants will be recruited from approximately 4,100 patients with asymptomatic and symptomatic SARS-CoV-2 infection during pregnancy who gave birth at the MFMU Network hospital.
The research team will periodically assess patients’ symptoms over a four-year period and evaluate their offspring for neurological symptoms and cardiovascular conditions.
Researchers led by Torri Metz, MD, of the University of Utah School of Medicine, will seek to understand what proportion of patients with Covid-19 in pregnancy at risk for long Covid.
What is the severity Covid-19 in pregnancy affects the likelihood of developing long Covid, and what proportion of patients develop PASC after Covid-19 in pregnancy compared with nonpregnant women who develop PASC.
The researchers hope the findings of this study will inform efforts to reduce the risk of long-term Covid in pregnant women or after pregnancy and to treat the symptoms.
The study will also follow up their offspring for possible long-term neurological or cardiovascular effects.
Previously, the US Centers for Disease Control and Prevention (CDC) had urged all pregnant women to get the vaccine Covid-19.
This is due to an increase in the number of pregnant women who are hospitalized due to Covid-19.
Of patients admitted to the hospital because of Covid-19Most of them will enter the intensive care unit (ICU).
Pregnant women are at higher risk of severe illness and pregnancy complications from the coronavirus, including possible miscarriage and stillbirth.
In addition, vaccine Covid-19 has also been tested for pregnant women and has been declared safe.
–
